TriMas (NASDAQ:TRS – Get Free Report) released its earnings results on Thursday. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.05), Zacks reports. TriMas had a net margin of 2.93% and a return on equity of 9.21%. TriMas updated its FY 2025 guidance to 1.700-1.850 EPS.
TriMas Stock Down 6.2 %
NASDAQ:TRS traded down $1.36 during midday trading on Thursday, reaching $20.51. 1,158,029 shares of the stock traded hands, compared to its average volume of 334,114. TriMas has a 12-month low of $19.33 and a 12-month high of $28.51. The business has a 50-day moving average of $23.95 and a two-hundred day moving average of $25.15. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The stock has a market capitalization of $832.13 million, a PE ratio of 32.05 and a beta of 0.66.
TriMas Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.78%. TriMas’s dividend payout ratio is presently 25.00%.
Analyst Ratings Changes
Check Out Our Latest Research Report on TRS
About TriMas
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Stories
- Five stocks we like better than TriMas
- What Is WallStreetBets and What Stocks Are They Targeting?
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What Are Dividends? Buy the Best Dividend Stocks
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.